WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Now Take That fans are left fuming after venue change from crisis
International Nurses Day Marked Across China
Victims of China Plane Crash Mourned
China to Reinforce Its Employment
Larsa Pippen flashes diamonds on THAT finger while out with on
Boao Forum for Asia Focuses on Green Recovery, Sustainable Development
Farms a Hive of Activity Across China
China Issues White Paper on Its Youth in New Era
Turkey says it has carried out new airstrikes against Kurdish militants in northern Iraq
People participate in Malaysia
Powerful ethnic armed group in western Myanmar claims to capture base and hundreds of soldiers
Kunming Combines Jacaranda Scenery, Cultural Creativity to Boost Tourism